PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 4, 2026European Cells and Materials2 citationsOpen Access

Exosomes in tissue engineering and cell-free therapy: A comprehensive review

View Full Paper
LZL. ZhangFYF.F. YangJLJianhong Liu

Key Points

  • This review aims to analyze the capabilities and applications of exosomes in tissue engineering and cell-free therapy.
  • Systematic review of exosome biogenesis, isolation, and characterization.
  • Assessment of exosome roles in various regenerative medical applications.
  • Analysis of innovative strategies for engineering exosomes and their integration with biomaterials.
  • Discussion of future directions involving AI and 3D bioprinting.
  • Exosomes demonstrated regulatory roles in bone/cartilage repair, neural regeneration, and wound healing.
  • Highlighted mechanisms include antiapoptotic, proangiogenic, and immunomodulatory functions.
  • Innovations suggested for improving exosome delivery systems and clinical applications.

Abstract

As a critical subclass of extracellular vesicles, exosomes have emerged as a research focus in tissue regeneration and precision therapy because of their unique molecular delivery and intercellular communication capabilities. This article systematically reviews the biogenesis, isolation, and characterization of exosomes and their role in advancing tissue engineering applications. Their multifaceted regulatory roles in bone/cartilage repair, neural regeneration, wound healing, and cardiovascular regeneration, including antiapoptotic, proangiogenic, immunomodulatory, and antifibrotic mechanisms, are highlighted. The innovations of this work lie in (1) the comprehensive analysis of engineered exosome strategies—such as surface modification, cargo-loading optimization, and synergistic integration with biomaterials—to overcome the limitations of traditional delivery systems; (2) the proposal of the dual regulatory potential of exosomesin cancer immunotherapy and autoimmune diseases, offering novel insights for clinical translation; and (3) the envisioning of future directions by integrating artificial intelligence (AI) and three-dimensional (3D) bioprinting to advance scalable production and precision design of exosome-based therapies. This article further addresses current challenges (e.g., heterogeneity, standardization, and safety) and emphasizes interdisciplinary collaboration to bridge the gap between fundamental research and clinical translation. This review provides a theoretical framework and technical foresight for advancing regenerative medicine and precision therapeutics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69a7cce8d48f933b5eed8c4ahttps://doi.org/10.22203/ecm.v055a06
Ask AI
Helpful
Bookmark
Share
View Full Paper